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Background: Nucleic acid amplification technologies (NAAT) are advancing our ability to make rapid molecular
diagnoses in patients with serious culture negative infections. This is the first report of PCR coupled to electrospray
ionization mass spectrometry use in the evaluation of complicated community acquired pneumonia in a pediatric
patient.
Case presentation: We present a case of culture negative empyema in a critically ill, Caucasian, 2-year-old girl who
was treated with broad-spectrum empiric antibiotics, in which the length of stay was prolonged by adverse effects
of the empiric antibiotic treatment. PCR coupled to electrospray ionization mass spectrometry was applied to
culture negative fluid and tissue samples from the patient in order to determine the etiology of the empyema.
Conclusions: Using this method, Streptococcus mitis/viridans was identified as the pathogen. A retrospective review
of cases of empyema in children at our institution found that 87.5% of cases were negative for identification of a
pathogen and antibiotics were administered to 100% of cases prior to collecting pleural fluid for culture.
Understanding the role of Streptococcus mitis/viridans group in the etiology of empyema using an advanced NAAT
coupled with mass spectrometry can enlighten clinicians as to the impact of this pathogen in community acquired
pneumonia and help assist with antibiotic stewardship.
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Despite the introduction of the pneumococcal conjugate
vaccine into the childhood immunization schedule in
2000, community acquired pneumonia (CAP) remains
the most common infectious cause for hospitalization in
children. Given the impact of the pneumococcal vaccine
on pneumonia incidence, more uncertainty exists today
regarding the most likely microbiologic etiology when
cultures are negative. Additionally, empyema is a com-
mon complication of pediatric CAP. In more than 60%
of cases, pleural fluid or tissue fails to yield a pathogen.
Therefore, selecting appropriate antimicrobial therapy
for patients with evidence of infection, but negative
cultures is a common dilemma in practice.* Correspondence: eluciav@uic.edu; Robert.Bonomo@va.gov
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article, unless otherwise stated.Herein, we describe the application of PCR followed
by electrospray-ionization mass spectrometry (PCR/ESI-
MS) for detection of Streptococcus mitis directly from
“culture negative” pleural fluid in a 2 year-old girl with a
loculated parapneumonic effusion that developed during
broad spectrum empiric IV antibiotic treatment. This
case illustrates that PCR/ESI-MS may have a role as an
adjunct to conventional diagnostic microbiologic methods
in cases when cultures of specimens obtained following
the initiation of antibiotic treatment do not yield a
pathogen.
Case presentation
A previously healthy two-year-old girl was transferred to
our tertiary care center from her pediatrician’s office in
acute respiratory distress. Her symptoms began six days
before arrival with nasal congestion, sore throat, non-
productive cough and fever; her oral intake and activity
level had both decreased, as well. Her two siblings haded Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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tions, presumed to be due to a viral infection. The
patient also complained to her parents of pain in the ribs
and abdomen. In her pediatrician’s office, point of care
testing for Respiratory Syncytial Virus (RSV) and Group
A β-hemolytic streptococcal (GAS) infection were both
negative.
Her past medical history was unremarkable. She had
been a full term infant who was born by vaginal delivery
without complications. She had been diagnosed with
RSV infection at eight months of age, and had an un-
eventful recovery. Her immunizations were up-to-date,
and she had no allergies. She lives with mother, father
and two siblings, all of whom are non-smokers. The
family has no pets, and the family history was unremark-
able. In the developmental history, all milestones had
been achieved in a normal sequence and time.
On exam, she was initially afebrile: axillary temperature
was 36.6°C, respiratory rate and heart rate were 20
breaths/min and 138 beats per minute, respectively andTable 1 Laboratory results at admission, midpoint of hospita
Complete blood count Day 1













Blood urea nitrogen 13 mg/d
Creatinine 0.51 mg/dl
Total protein 5.6 gm/d
Albumin 2.7 gm/dl
Calcium 8.8 mg/dl
Total bilirubin 0.4 mg/dl
Alanine transaminase 25 U/L
Aspartate transaminase 22 U/L
Alkaline phosphatase 186 U/L
Microbiology Blood cultures
BACTEC™ culture bottles No growth
Aerobic Culture –
PCR/ESI-MS –blood pressure was 138/77 mmHg. Height was 36.6″
inches (63% percentile) and weight 16.3 kg (96% percent-
ile). Pulse oximetry was 93% on room air. She was listless.
Her head, ear, eyes, nose and throat exam were unre-
markable. There was no cervical lymphadenopathy. She
was tachycardic, but the rhythm was regular, and no
murmur was appreciated. Pulmonary examination was
notable for diminished breath sounds on the left. Ab-
dominal, neurological, skin and musculoskeletal exam
were unremarkable.
Laboratory studies on the day of admission showed
leukocytosis, anemia, and decreased albumin (Table 1).
A two view chest X-ray was notable for a left lung infil-
trate. Low dose screening computer tomography (CT)
scan of the chest demonstrated a left upper lobe pneu-
monia with decreased contrast enhancement of the left
upper lobe, concerning for left upper lobe ischemia, and
a moderate to large left pleural effusion, but no evidence
for empyema or compressive atelectasis of the left lower
lobe (Figure 1).l stay, and discharge
Day 5 Day 10
19,400 cells/dL 13,200 cells/dL
73% neutrophils 64% neutrophils
es 17% lymphocytes 27% lymphocytes
9% monocytes 8% monocytes
7.3 g/dL 8.8 g/dL
23% 23%
350 thous/UL 595 thous/UL















Pleural Fluid Operative (VATS)
No growth –
– No growth
mitis/viridans streptococci mitis/viridans streptococci
Figure 1 Images of CT scan of chest obtained from 2 year old child with empyema. A) Large pleural effusion with resulting left lower lobe
compressive atelectasis. B) Left upper lobe consolidation with air bronchogram.
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(IV) antibiotics were started: IV clindamycin and ceftri-
axone. Despite therapy, she continued to experience
fevers to 39°C. On hospital day 2, blood cultures from
admission remained negative, but because of persistent
fever (T 39.4°C), tachycardia (HR 175), respiratory dis-
tress, and leukocytosis (WBC count = 17,000 cells/dL) a
diagnostic thoracoscopy with placement of a 20 French
chest tube (CT) into the posterior left pleural space was
performed. During the thoracoscopy, a 5 mm camera
was inserted to inspect the lung and pleural space, which
was found to contain straw colored fluid that was free of
fibrinous material. Pleural fluid was submitted for both
aerobic and anaerobic cultures, which were negative.
Gram stain showed no organisms.
The patient remained febrile with daily temperatures
up to 40.0°C (104°F) and tachycardic (sinus HR ranged
from 136 to 175 bpm). On hospital day five, cultures of
the fluid drained during CT insertion remained negative(Table 1). A repeat ultrasound of the chest showed a
complex left pleural effusion containing internal debris
and septations. In spite of three tissue plasminogen
activator infusions through the chest tube, the effusion
remained loculated and failed to drain. On hospital day
six, video-assisted thoracic surgery (VATS) with de-
cortication of necrotic tissue was performed along with
placement of two large bore chest tubes. Cultures of tis-
sue obtained during the VATS procedure were negative.
On hospital day eight, the patient developed abdominal
distention secondary to adynamic ileus. Stool softeners
were started which helped regulate stool patterns as well
as the ileus. She received a total of 9 days of IV clinda-
mycin and IV ceftriaxone. On the day of discharge, hos-
pital day 10, the chest tubes were removed, and the
antibiotic treatment was changed to oral amoxicillin/cla-
vulanate. She tolerated this medication well, and she was
discharged with a plan to complete 10 additional days of
treatment (Table 1).
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hospital discharge. Her mother reported that she was
tolerating the oral antibiotic, she had no diarrhea and
her appetite had improved, but she continued to have
abdominal distension. She was afebrile. Her lung exam
was still notable for diminished breath sounds at the left
base. The abdomen was mildly distended; surgical inci-
sions were intact and healing nicely and there was no
evidence of active infection. Conservative measures were
prescribed for treatment of the abdominal distension.
She completed antimicrobial treatment without further
incident, and recovered completely from her infection.
Informed consent was obtained from the parents of
the patient for publication of this case report and any
accompanying images. A copy of the written consent is
available for review by the Editor of this journal.
PCR/ESI-MS
PCR/ESI-MS is a rapid molecular diagnostic platform
that identifies pathogens across the entire spectrum of
disease processes: bacteria, viruses, parasites, and fungi.
PCR/ESI-MS has also demonstrated the capacity to de-
tect pathogenic organisms in clinical samples obtained
following initiation of antimicrobial treatment [1]. Add-
itional primer pairs target genes for antibiotic resistance
or particular pathogenic features. Compared to clinical
samples, the PCR/ESI-MS performs with 98.7% and
96.6% concordance at the genus and species levels,
respectively [2].
PCR/ESI-MS (Ibis Biosciences, Carlsbad, CA) was per-
formed on “culture negative” fluid and tissue samples
from the patient: 2 mL of pleural fluid obtained at the
time of initial chest tube insertion; and tissue from the
loculated left sided empyema obtained during VATS.
We followed the protocol previously described and vali-
dated by Kaleta et al. [2]. PCR/ESI-MS detected mitis/
viridans group streptococci from the patient’s pleural
fluid and tissue samples. As noted, the patient expe-
rienced complications associated with broad empiric
antibiotic treatments that were likely attributable to clin-
damycin. Fortunately, the patient recovered completely
from her infection, and the gastrointestinal side effects of
antimicrobial treatment eventually resolved, but incorp-
oration of molecular testing into her diagnostic evalu-
ation may have averted the prolonged hospital stay.
Mitis/viridans streptococci are an uncommon cause of
empyema. To determine if the patient was unique, IRB
approval was obtained for retrospective review of all
cases of pleural effusion in children ≤18 years of age
hospitalized at our institution with empyema between
January 1, 2013 and December 31, 2013. Patient consent
was not needed for this retrospective chart review.
We identified fourteen patients with parapneumonic
effusion or empyema. Only three patients had evidenceof septations and/or loculation in the effusion on chest
imaging. Eight pleural fluid samples from six patients were
submitted for culture: Gram stain and cultures were nega-
tive in 87.5% of specimens (7/8). All of the patients had
been treated with antibiotics before pleural fluid was ob-
tained for culture; the median duration of treatment was
8 days. The only positive pleural fluid culture grew methi-
cillin susceptible S. aureus from fluid drained following
two doses of antibiotic treatment, but when a second sam-
ple of pleural fluid was aspirated from this child after
4 days of antibiotic treatment, the cultures were negative.
Results and discussion
Selecting appropriate antimicrobial therapy for patients
with evidence of infection but negative cultures is a
common dilemma especially in cases of empyema [3-5].
Pediatric Infectious Diseases Society and the Infectious
Diseases Society of America guidelines for management
of CAP recommend empiric treatment with IV ampicil-
lin in fully immunized patients older than 5 years of age,
but in a child with “culture negative” empyema there are
no clear guidelines for treatment [6]. The patient was
treated empirically with both ceftriaxone and clindamy-
cin for both streptococcal and staphylococcal infection
for two days before pleural fluid was sent for culture.
This choice of antimicrobial therapy was influenced by
the severity of her infection, including altered mental
status demonstrated by listlessness, and CT scan findings
of lung ischemia.
Even with widespread recognition that early interven-
tion with VATS is associated with improved outcomes,
the proportion of patients with negative pleural fluid
and tissue cultures remains over 60% in patients with
loculated effusions not responding to fibrinolysis [3-5].
In our retrospective review of all children ≤18 years of
age hospitalized at our institution with parapneumonic
effusion or empyema, 100% of the patients had been
treated with antibiotics for at least 48 hours before
pleural fluid was submitted for culture. We previously
demonstrated bacterial pathogens are present and read-
ily detected by molecular testing in 60% of patients with
negative cultures when the samples have been obtained
after 48 hours of empiric antibiotic treatment [1].
Molecular testing has improved sensitivity over culture
for detection of bacterial pathogens from pleural fluid
[3]. Unfortunately, molecular testing is not routinely
available, and the turnaround time for send-out testing
is too slow to impact routine care of inpatients. Specific
PCR testing for MRSA is commonly available, but MR-
SA empyema and parapneumonic effusions remain
extremely uncommon in pediatric patients [3,5], and the
applicability of PCR assays in clinical practice is limited
by the positive vs. negative result inherent in conven-
tional diagnostic PCR assays.
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Our case provides further support to the growing body
of evidence that molecular diagnostics will play a role
as an adjunct to conventional diagnostic microbiologic
methods in culture negative cases of empyema and para-
pneumonic effusion. We suggest that when growth of
organisms is inhibited by prior antibiotic treatment, par-
ticularly when Gram stain suggests non-viable organisms
are present, molecular testing such as PCR/ESI-MS may
provide an opportunity to narrow treatment. Our under-
standing of pleural space infections will undoubtedly
benefit from more widespread use of molecular diagnos-
tics such as nested PCR, 16S ribosomal gene sequencing,
and PCR/ESI-MS. Future investigations conducted pro-
spectively to analyze the diagnostic accuracy and utility
of these assays should be conducted before empirical
antimicrobial treatment is replaced by specific treatment
targeting organisms identified in molecular assays.
Key messages
1) Novel molecular diagnostics can have a significant
impact on the diagnosis of serious culture negative
infections of the lung and chest.
2) Understanding the role of Streptococcus mitis/
viridans group in the etiology of empyema using
advanced nucleic acid amplification technologies
coupled with mass spectrometry can enlighten
clinicians as to the impact of this pathogen in CAP
and help with antibiotic stewardship.
Abbreviations
PCR: Polymerase chain reaction; DNA: Deoxyribonucleic acid;
PCR/ESI-MS: Polymerase chain reaction/electrospray ionization-mass
spectrometry; VATS: Video-assisted thoracoscopy surgery.
Competing interests
RS and KL are salaried employees of Ibis Biosciences, a division of Abbott.
Authors’ contributions
ELVM framed the clinical approach, managed the patient, and drafted the
manuscript. JJF helped draft manuscript. RS designed and interpreted
molecular assays. AMH helped draft the manuscript. KSL designed and
interpreted molecular assays. RAB helped draft manuscript. All authors read
and approved the final manuscript.
Acknowledgements
Funds and facilities provided by the Cleveland Department of Veterans
Affairs, the Veterans Affairs Merit Review Program award number
1I01BX001974, and the Geriatric Research Education and Clinical Center VISN
10 to RAB supported this work.
This work was also supported by funds from the National Institute of Allergy
and Infectious Diseases of the National Institutes of Health under award
numbers R01AI063517 and R01AI100560 to RAB, and through the Antibiotic
Resistance Leadership Group under National Institutes of Health award
number UM1AI104681, and NIH award number R01AI072219. Funding
organizations were not involved in the design and conduct of the study;
collection, management, analysis, and interpretation of the data; and
preparation, review, or approval of the manuscript.
The content is solely the responsibility of the authors and does not
necessarily represent the official views of the National Institutes of Health or
the Department of Veterans Affairs.Author details
1Departments of Medicine & Pediatrics, University of Illinois School of
Medicine, 530 N.E. Glen Oak Ave, Peoria, IL 61603, USA. 2Department of
Medicine, University of Illinois School of Medicine, Peoria, IL, USA. 3Louis
Stokes Cleveland Department of Veterans Affairs Medical Center, Research
Service, 10701 East Blvd, Cleveland, Ohio 44106, USA. 4Department of
Medicine, Case Western Reserve University, Cleveland, OH, USA. 5Ibis
Biosciences, an Abbott Company, Carlsbad, CA, USA. 6Departments of
Pharmacology and Molecular Biology and Microbiology, Case Western
Reserve University, Cleveland, OH, USA.
Received: 30 May 2014 Accepted: 10 November 2014
Published: 22 November 2014
References
1. Farrell JJ, Sampath R, Ecker DJ, Bonomo RA: “Salvage microbiology”:
detection of bacteria directly from clinical specimens following initiation
of antimicrobial treatment. PLoS One 2013, 8(6):e66349.
2. Kaleta EJ, Clark AE, Johnson DR, Gamage DC, Wysocki VH, Cherkaoui A,
Schrenzel J, Wolk DM: Use of PCR coupled with electrospray ionization
mass spectrometry for rapid identification of bacterial and yeast
bloodstream pathogens from blood culture bottles. J Clin Microbiol 2011,
49(1):345–353.
3. Blaschke AJ, Heyrend C, Byington CL, Obando I, Vazquez-Barba I, Doby EH,
Korgenski EK, Sheng X, Poritz MA, Daly JA, Mason EO, Pavia AT, Ampofo K:
Molecular analysis improves pathogen identification and epidemiologic
study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011,
30(4):289–294.
4. Schultz KD, Fan LL, Pinsky J, Ochoa L, Smith EO, Kaplan SL, Brandt ML: The
changing face of pleural empyemas in children: epidemiology and
management. Pediatrics 2004, 113(6):1735–1740.
5. Grisaru-Soen G, Eisenstadt M, Paret G, Schwartz D, Keller N, Nagar H, Reif S:
Pediatric parapneumonic empyema: risk factors, clinical characteristics,
microbiology, and management. Pediatr Emerg Care 2013, 29(4):425–429.
6. Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan
SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA,
Swanson JT: Pediartric Infectious Diseases Society and the Infectious
Diseases Society of America: The management of community-acquired
pneumonia in infants and children older than 3 months of age: Clinical
practice guidelines by the Pediatric Infectious Diseases society and the
Infectious Diseases Society of America. Clin Infect Dis 2011, 53(7):e25–76.
doi:10.1186/1471-2253-14-107
Cite this article as: Vazquez Melendez et al.: Culture negative empyema
in a critically ill child: an opportunity for rapid molecular diagnostics.
BMC Anesthesiology 2014 14:107.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
